April 8, 2020

Endocrinologists Called to Restrict Glucocorticoid Prescriptions to Aid in COVID-19 Crisis Endocrinologists make can a difference in COVID-19 by restricting their use of glucocorticoids. According to an editorial published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism, patients treated with glucocorticoids will be at higher risk for coronavirus disease 2019 (COVID-19), the infection caused by the novel coronavirus.   ADVERTISEMENT

Endocrinology, Diabetes, and COVID-19: An Interview with Paul Stewart, M.D. Patrick Campbell sat down with Paul Stewart, MD, Executive Dean of the Faculty of Medicine and Health at University of Leeds and editor in chief of the Journal of Clinical Endocrinology & Metabolism to discuss why endocrinologists are expressing additional concern for their patients during the COVID-19 outbreak.

Why Older Patients Are More At Risk for COVID-19 : A Decline In ACE2 Expression A new perspective from a team of Maryland-based cardiovascular clinicians sheds insight on an often forgotten facet of the inherent COVID-19 risk carried by patients with cardiovascular history: the decline in angiotensin-converting enzyme 2 (ACE2) expression associated with aging, and the response of care most common in such patients.

The Location of Broken Bones Predicts Life Expectancy in Elderly Patients The location of a broken bone can significantly impact the long-term health outcomes of older individuals, according to the new research findings to be presented at the Endocrine Society (ENDO) 2020 Annual Scientific Sessions.

When Detecting Broken Bones Computers Outperform People An artificial intelligence tool trained to pinpoint patients with broken bones who are also at risk for osteoporosis outperforms radiologists who manually read the reports, a new study has found.

Hypothyroidism Screening Needed for Patients with Alkaptonuria Screening for hypothyroidism should be considered for patients with alkaptonuria, according to recent study findings.

Early Puberty Could Help Predict Risk of Diabetes New research from a team of European investigators suggests age at the onset of puberty could serve as an independent risk factor for type 2 diabetes (T2D).

ACE Inhibitors & ARBs: Wading Into the Unknown of COVID-19 What is the role of ACE inhibition or angiotensin receptor blockers (ARBs) within regard to the novel coronavirus (COVID-19)?

IN CASE YOU MISSED IT….

Metformin Protects Hearts of Diabetic Transplant Recipients Transplanted hearts are protected by the diabetes drug Metformin, when the recipient is diabetic a study in the Journal of the American College of Cardiology finds.

Cardiology Organizations Advise on ACE Inhibitors, ARBs Use During COVID-19 In the face of the worldwide coronavirus (COVID-19) pandemic, 4 of the largest cardiology organizations are advising patients receiving treatment with ACE inhibitors (ACE-i) and angiotensin receptor blockers (ARBs) they should not be discontinuing treatment unless it is recommended by their physician. Find out more.

We want to hear from you! Did you love an article you read in Practical Cardiology? Disagree with an author’s conclusions? Want to share how you solved an issue in your practice? Then Practical Cardiology editors want to hear from you! Please send your comments to GCudaKroen@mjhlifesciences.com.